Skip to Main Content
Back to News

Lobbying Update: $60,000 of DANAHER CORPORATION lobbying was just disclosed

None

$60,000 of DANAHER CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Education campaign with policymakers related to life sciences and biotechnology issues"

You can find more data on corporate lobbying on Quiver Quantitative.

DHR Insider Trading Activity

DHR insiders have traded $DHR stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:

  • DANIEL RASKAS (SVP - Corporate Development) has traded it 3 times. They made 0 purchases and 3 sales, selling 49,195 shares.
  • GEORGEANN COUCHARA (SVP, Human Resources) sold 952 shares.
  • LINDA FILLER sold 3,928 shares.
  • MATTHEW MCGREW (EVP & Chief Financial Officer) sold 16,172 shares.
  • RAINER BLAIR (President & CEO) sold 9,007 shares.
  • BRIAN W ELLIS (Senior Vice President - GC) sold 9,600 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DHR Hedge Fund Activity

We have seen 1,010 institutional investors add shares of DHR stock to their portfolio, and 925 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles